Survival Patients Toxicity Treatment Hospital Country Date
29.2 months Malignant Pleural Mesothelioma 3 Chemotherapy Immunotherapy Center Hospitalier Intercommunal de Creteil France 6/2002
26.8 months Pleural mesothelioma 5 Chemotherapy H. Lee Moffitt Cancer Center and Research Institute United States 7/2008
26.0 months Mesothelioma 3 Chemotherapy Immunotherapy Radiation Surgery University of Pisa Italy 12/2006
23.0 months MPM 5 Chemotherapy Surgery University Hospital Zurich Switzerland 4/2007
23.0 months Malignant pleural mesothelioma 3 Biologic therapy Surgery New York University School of Medicine United States 8/2008
18.1 months Malignant Pleural Mesothelioma 5 Radiation < Surgery University of California, San Francisco United States 12/2002
18.0 months Malignant Pleural Mesothelioma 3 Immunotherapy Hopital de la Conception France 11/1998
17.8 months Malignant Pleural Mesothelioma 5 Biologic therapy < Chemotherapy Medical University of Lubeck Germany 3/2003
16.8 months Malignant pleural mesothelioma 4 Chemotherapy Radiation Surgery Memorial Sloan-Kettering Cancer Center United States 6/2009
15.0 months Malignant Pleural Mesothelioma 3 Immunotherapy Ospedale S. Spirito Italy 2/2001
14.8 months Malignant Pleural Mesothelioma 4 Chemotherapy Newcastle General Hospital United Kingdom 8/2002
14.0 months Malignant Pleural Mesothelioma 4 Chemotherapy Ospedale ‘Villa Scassi’ Italy 12/2007
14.0 months Malignant pleural mesothelioma 5 Surgery Memorial Sloan-Kettering Cancer Center United States 3/2008
13.1 months Malignant pleural mesothelioma 5 Chemotherapy Surgery Brigham and Women’s Hospital United States 8/2009
13.0 months Malignant Pleural Mesothelioma 4 Alternative Chemotherapy University of Turin Italy 4/2003
13.0 months Mesothelioma 5 Chemotherapy Surgery Brigham and Women’s Hospital United States 4/2006
12.7 months Malignant Pleural Mesothelioma 4 Chemotherapy Istituto Clinico Humanitas Italy 3/2006
12.7 months MPM 4 Chemotherapy Immunotherapy C. Forlanini Hospital Italy 1/2005
12.4 months Malignant pleural mesothelioma Surgery Medical University of Vienna Austria 4/2008
12.1 months Malignant Pleural Mesothelioma 5 Alternative Chemotherapy University of Chicago, Cancer Research Center United States 7/2003
12.0 months Malignant Pleural Mesothelioma 3 Radiation Surgery The University of Texas M. D. Anderson Cancer Center United States 3/2003
11.2 months MPM 5 Chemotherapy Emory University School of Medicine United States 5/2005
11.2 months Malignant pleural mesothelioma 4 Chemotherapy Sir Charles Gairdner Hospital Australia 8/2002
10.6 months Malignant Pleural Mesothelioma 4 Chemotherapy St Bartholomew’s Hospital United Kingdom 12/2000
10.5 months Malignant Mesothelioma 3 Biologic therapy < Chemotherapy The Royal Marsden Hospital United Kingdom 2/2002
10.3 months Malignant peritoneal mesothelioma 5 Chemotherapy Cardarelli Hospital Italy 5/2009
10.1 months Malignant pleural mesothelioma 4 Chemotherapy Institut Gustave Roussy France 1/2003
10.1 months Malignant pleural mesothelioma 4 Chemotherapy Dana Farber Cancer Institute United States 3/2008
10.0 months Malignant Mesothelioma 4 Chemotherapy National University Hospital, Rigshospitalet Denmark 4/1999
10.0 months Malignant pleural mesothelioma 4 Radiation Surgery Memorial Sloan-Kettering Cancer Center United States 10/2001
10.0 months Malignant Pleural Mesothelioma 5 Biologic therapy Surgery The Netherlands Cancer Institute Netherlands 10/2001
9.7 months Advanced malignant pleural mesothelioma 4 Chemotherapy Medical University of Gdansk Poland 4/2008
9.6 months Malignant Mesothelioma 5 Chemotherapy University of Chicago Medical Center United States 11/1999
9.6 months Malignant pleural mesothelioma 4 Chemotherapy Charing Cross Hospital United Kingdom 5/2008
9.5 months Malignant pleural mesothelioma 5 Chemotherapy Leeds General Infirmary United Kingdom 5/2008
9.4 months Malignant Pleural Mesothelioma 4 Chemotherapy University Hospital Rotterdam Netherlands 2/2002
9.3 months MPM 5 Chemotherapy University of Chicago United States 6/2005
9.3 months Malignant Pleural Mesothelioma 4 Chemotherapy Immunotherapy Istituto Clinico Humanitas Italy 8/2001
9.3 months Malignant Pleural Mesothelioma 4 Alternative Chemotherapy University of Chicago, Cancer Research Center United States 7/2003
9.0 months Malignant Pleural Mesothelioma 2 Immunotherapy St. Bartholomew’s Hospital United Kingdom 1/2001
8.8 months MPM 4 Chemotherapy St. Bartholomew’s Hospital United Kingdom 2/2005
8.8 months Malignant Pleural Mesothelioma 4 Chemotherapy University Hospital Vrije Universiteit Netherlands 11/1997
8.7 months Malignant Pleural Mesothelioma 1 Radiation Sir Charles Gairdner Hospital Australia 7/2004
8.5 months Malignant Pleural Mesothelioma 4 Chemotherapy The University of Texas M.D. Anderson Cancer Center United States 8/2000
8.2 months Malignant Pleural Mesothelioma 4 Chemotherapy Erasmus Medical Center Netherlands 4/2002
8.0 months Malignant Pleural Mesothelioma 4 Chemotherapy University of Turin Italy 4/2003
7.6 months MPM 3 Biologic therapy Netherlands Cancer Institute Netherlands 5/2005
7.0 months Malignant pleural mesothelioma 3 Chemotherapy The Netherlands Cancer Institute Netherlands 2/2003
7.0 months Malignant Mesothelioma 5 Chemotherapy Columbia University United States 7/2003
6.8 months Advanced mesothelioma 5 Chemotherapy Washington University School of Medicine United States 3/2005
6.6 months Malignant Mesothelioma 4 Chemotherapy University of Chicago Medical Center United States 11/1999
6.0 months Unresectable Malignant Mesothelioma 4 Chemotherapy Alfacell Corp. United States 1/2002
5.8 months Malignant pleural mesothelioma 4 Biologic therapy Dana-Farber Cancer Institute United States 6/2008
4.9 months Malignant Mesothelioma 5 Chemotherapy Ohio State University Comprehensive Cancer Center United States 5/2004
4.8 months Malignant Mesothelioma 5 Chemotherapy Scripps Clinic United States 11/2001
4.7 months Malignant Mesothelioma 5 Chemotherapy University of Chicago Medical Center United States 2/2001
3.2 months MPM 3 Chemotherapy San Matteo University Hospital Italy 6/2005
N/R Mesothelioma 3 Alternative University of Texas, M. D. Anderson Cancer Center United States 3/2001
N/R MPM 4 Biologic therapy Erasmus Medical Center Netherlands 2/2005
More Mesothelioma 4 Immunotherapy Memorial Hermann Hospital United States 12/2002
More Mesothelioma 4 Biologic therapy Massachusetts General Hospital United States 2/2001
More Malignant Pleural Mesothelioma 4 Chemotherapy IST Istituto Nazionale per la Ricerca sul Cancro Italy 11/2001
More Mesothelioma 4 Chemotherapy University of Minnesota Medical School United States 1/2002